ArticleBMC pregnancy and childbirth2026
Evaluation of systemic immune-inflammatory biomarkers in eclampsia: a retrospective cohort study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate systemic immune-inflammatory biomarkers in patients diagnosed with eclampsia and to investigate their potential association with inflammation.
methodsThis retrospective study included 31 patients with eclampsia and 51 healthy pregnant women matched for age and parity. Hematological biomarkers-including NLR, MLR, PLR, SII, SIRI, PNR, dNLR, and AISI-were calculated using complete blood count data collected prior to delivery. Statistical comparisons between groups were performed using appropriate tests based on data distribution.
resultsThere were no statistically significant differences in NLR, MLR, SII, SIRI, dNLR, or AISI between groups (p > 0.05). The PLR and PNR levels were significantly lower in the eclampsia group (p = 0.021 and p = 0.044). Additionally, the eclampsia group had significantly lower gestational age and neonatal birth weight, and higher rates of cesarean section, ICU admission, and maternal complications (all p < 0.001).
conclusionThis study found no significant association between eclampsia and most systemic immune-inflammatory biomarkers. PLR and PNR values were significantly lower in the eclampsia group. These markers may serve as potential negative predictive biomarkers, but their diagnostic value remains limited. Further prospective studies are needed to clarify their clinical utility in eclampsia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.